ElevateBio
ElevateBio, a cell and gene therapy firm, develops and commercializes transformative medicines, swiftly turning R&D into viable therapies.
Founded
2017ElevateBio, a cell and gene therapy firm, develops and commercializes transformative medicines, swiftly turning R&D into viable therapies.
elevate.bioCrawled Oct 15, 2026
BaseCamp is for cell and gene therapy product development across the product life cycle.
ElevateBio’s integrated technology platforms enable a range of advanced cell and gene therapies.
ElevateBio is the first manufacturer to achieve ICMC certification across viral gene delivery, non-viral gene delivery, and cell therapy products.
ElevateBio’s facilities support the discovery, development, and manufacture of advanced therapies. The page lists cGMP manufacturing facilities and a corporate headquarters and BaseCamp in Waltham, Ma.
The event celebrates partnerships advancing cell therapy development through conversation and collaboration.
The team shares information about the cell and gene therapy industry, including gene editing and biomanufacturing.
LETI-101 is a precision editing candidate for Huntington’s disease, presented as a potential one-time treatment and seeking a partnership.
The company offers technologies and manufacturing capabilities to support therapy development at any point in the product lifecycle.
Boston Globe Top Place to Work in 2022 and 2023 International Society for Pharmaceutical Engineering (ISPE) 2021 FOYA Award for “Operational Excellence”
ElevateBio is presenting 10 presentations at the 29th Annual ASGCT Meeting on gene editing modalities, AI-powered protein discovery, non-viral delivery, and other capabilities. These are available to partners through flexible engagement models.
The company says it can support therapy development at any point in the product lifecycle.
Media News, Media, & Presentations Stay up-to-date with the latest news from across the ElevateBio ecosystem. Press Releases All Press Featured News All Featured News
ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come.
Bhakti has more than 20 years of experience in biotech, consulting, and financial services, including corporate finance, business development, strategy, and business process re-engineering.
David Hallal has 30 years of experience in the biopharmaceutical industry, including early-stage company building and operating large multinational biotech companies. He co-founded ElevateBio.
Missy has more than 15 years of experience in operations and people strategies and advises the leadership team on operational improvement.
The company’s team includes scientists, builders, and operators who work on creating cell and gene therapies.
ElevateBio’s mission is to power the creation of cell and gene therapies.
The company says its values are central to its work.
ElevateBio is a technology-driven company whose integrated model combines platform technologies and cGMP manufacturing to power the creation of advanced therapies.
The page provides contact information, including the general inquiries email info@elevate.bio, and describes how the company’s ecosystem can guide projects from concept to commercialization.
ElevateBio commercializes its technologies, manufacturing capabilities, and expertise through partnerships to accelerate development across therapeutic approaches and modalities.
ElevateBio is powering the industry with an integrated approach to technologies and manufacturing
ElevateBio says it respects the privacy of patients, HCPs, colleagues, and other third parties with whom it interacts.